Related Experiment Video
Updated: Jan 14, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Apathy and cognitive decline as the first presentation of SLE-associated vascular dementia: a case report
Syed Ali Bokhari1, Dania Al-Ayyat2, Anood Shukry2
1Al Amal Psychiatric Hospital, Emirates Health Services, Dubai, United Arab Emirates. sab_191@live.com.
Abstract:
Apathy is a frequently overlooked yet disabling neuropsychiatric symptom in dementia syndromes, often misdiagnosed as depression. We describe a diagnostically challenging presentation of subcortical ischaemic vascular dementia in a 48-year-old Middle Eastern man, whose primary symptom was progressive apathy rather than overt cognitive decline or focal neurological deficits. Despite repeated emergency visits and antidepressant trials, his condition deteriorated until detailed neuropsychiatric evaluation and neuroimaging revealed right temporal gliosis/encephalomalacia, left frontal periventricular change, and multiple chronic lacunar infarcts in the left thalamus and bilateral centrum semiovale, on a background of small-vessel disease. Autoimmune workup confirmed previously undiagnosed systemic lupus erythematosus (SLE) with antiphospholipid markers, providing a unifying explanation for his vascular pathology. The clinical course was stepwise over ~ 18 months, with intermittent falls. Management included psychosocial interventions, behavioural support planning, and cautious pharmacological strategies; anticoagulation and rheumatological therapy were considered in light of his autoimmune risk. The patient showed modest improvements in affective responsiveness and engagement. This case highlights how apathy can be an early and dominant manifestation of vascular dementia when frontal-subcortical circuits are compromised. It underscores the need to differentiate apathy from depression using behavioural observations, collateral history, and cognitive testing, and to consider autoimmune vasculopathies in younger patients with unexplained vascular lesions. Timely neuroimaging and autoimmune screening could enable earlier diagnosis and intervention, improving outcomes in autoimmune-associated cognitive disorders.
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction

